These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9536244

  • 1. Psoriasis vulgaris treated successfully with mycophenolate mofetil.
    Haufs MG, Beissert S, Grabbe S, Schütte B, Luger TA.
    Br J Dermatol; 1998 Jan; 138(1):179-81. PubMed ID: 9536244
    [Abstract] [Full Text] [Related]

  • 2. Plasma trough levels of mycophenolic acid do not correlate with efficacy and safety of mycophenolate mofetil in psoriasis.
    Daudén E, Sánchez-Peinado C, Ruiz-Genao D, García-F-Villalta M, Onate MJ, García-Díez A.
    Br J Dermatol; 2004 Jan; 150(1):132-5. PubMed ID: 14746627
    [Abstract] [Full Text] [Related]

  • 3. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.
    Grundmann-Kollmann M, Mooser G, Schraeder P, Zollner T, Kaskel P, Ochsendorf F, Boehncke WH, Kerscher M, Kaufmann R, Peter RU.
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866
    [Abstract] [Full Text] [Related]

  • 4. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.
    Kitchin JE, Pomeranz MK, Pak G, Washenik K, Shupack JL.
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):445-9. PubMed ID: 9308561
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients.
    Geilen CC, Arnold M, Orfanos CE.
    Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019
    [Abstract] [Full Text] [Related]

  • 6. Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis.
    Davison SC, Morris-Jones R, Powles AV, Fry L.
    Br J Dermatol; 2000 Aug; 143(2):405-7. PubMed ID: 10951153
    [Abstract] [Full Text] [Related]

  • 7. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC, Orfanos-Boeckel H, Offermann G, Orfanos CE.
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [Abstract] [Full Text] [Related]

  • 8. A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.
    Beissert S, Pauser S, Sticherling M, Frieling U, Loske KD, Frosch PJ, Haase I, Luger TA.
    Dermatology; 2009 Feb; 219(2):126-32. PubMed ID: 19546522
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trial.
    Zhou Y, Rosenthal D, Dutz J, Ho V.
    J Cutan Med Surg; 2003 Feb; 7(3):193-7. PubMed ID: 12704533
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
    Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ.
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil and skin diseases.
    Hartmann M, Enk A.
    Lupus; 2005 Feb; 14 Suppl 1():s58-63. PubMed ID: 15803935
    [Abstract] [Full Text] [Related]

  • 12. Enteric-coated mycophenolate sodium: therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patients.
    Sollinger H.
    Transplant Proc; 2004 Mar; 36(2 Suppl):517S-520S. PubMed ID: 15041399
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
    Grundmann-Kollmann M, Korting HC, Behrens S, Kaskel P, Leiter U, Krähn G, Kerscher M, Peter RU.
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927
    [Abstract] [Full Text] [Related]

  • 14. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

  • 15. [Use of mycophenolate mofetil in kidney transplantation].
    Hrvacevic R, Ignjatovic Lj, Vavic N.
    Vojnosanit Pregl; 2001 Apr 15; 58(4):415-9. PubMed ID: 11712223
    [Abstract] [Full Text] [Related]

  • 16. Severe generalized pustular psoriasis treated with mycophenolate mofetil.
    Ji YZ, Geng L, Ma XH, Wu Y, Zhou HB, Li B, Xiao T, Chen HD.
    J Dermatol; 2011 Jun 15; 38(6):603-5. PubMed ID: 21352286
    [No Abstract] [Full Text] [Related]

  • 17. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment.
    Hutchinson P, Jose M, Atkins RC, Holdsworth SR.
    Transpl Immunol; 2004 Jun 15; 13(1):55-61. PubMed ID: 15203129
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M, Chams-Davatchi C, Hemami MR, Fateh S.
    J Eur Acad Dermatol Venereol; 2010 Dec 15; 24(12):1447-51. PubMed ID: 20384673
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil.
    Zwerner J, Fiorentino D.
    Dermatol Ther; 2007 Dec 15; 20(4):229-38. PubMed ID: 17970888
    [Abstract] [Full Text] [Related]

  • 20. The use of Mycophenolate Mofetil (Cellcept) in renal transplantation.
    Vanrenterghem Y.
    Nephron; 1997 Dec 15; 76(4):392-9. PubMed ID: 9274835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.